Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Inventory (2016 - 2020)

Plus Therapeutics (PSTV) has disclosed Inventory for 11 consecutive years, with $107000.0 as the latest value for Q3 2020.

  • Quarterly Inventory changed 0.0% to $107000.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $107000.0 through Sep 2020, changed 0.0% year-over-year, with the annual reading at $107000.0 for FY2019, 0.0% changed from the prior year.
  • Inventory for Q3 2020 was $107000.0 at Plus Therapeutics, roughly flat from $107000.0 in the prior quarter.
  • The five-year high for Inventory was $4.5 million in Q2 2016, with the low at $107000.0 in Q4 2018.
  • Average Inventory over 5 years is $2.3 million, with a median of $3.0 million recorded in 2018.
  • The sharpest move saw Inventory rose 11.15% in 2016, then crashed 96.64% in 2018.
  • Over 5 years, Inventory stood at $3.7 million in 2016, then dropped by 14.55% to $3.2 million in 2017, then plummeted by 96.64% to $107000.0 in 2018, then changed by 0.0% to $107000.0 in 2019, then changed by 0.0% to $107000.0 in 2020.
  • According to Business Quant data, Inventory over the past three periods came in at $107000.0, $107000.0, and $107000.0 for Q3 2020, Q2 2020, and Q1 2020 respectively.